Summit X, LLC Age X Therapeutics, Inc. Transaction History

Summit X, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$0.33 - $0.74 $4,785 - $10,730	-14,500 Reduced 39.19%	22,500 $8,000
Q3 2023 Nov 03, 2023	BUY	$0.67 - $0.85 $8,040 - $10,200	12,000 Added 48.0%	37,000 $25,000
Q2 2023 Aug 09, 2023	SELL	$0.45 - $0.89 $3,375 - $6,675	-7,500 Reduced 23.08%	25,000 $22,000
Q1 2023 May 10, 2023	SELL	$0.56 - $0.8 $280 - $400	-500 Reduced 1.52%	32,500 $21,000
Q4 2022 Feb 02, 2023	BUY	$0.54 - $0.68 $270 - $340	500 Added 1.54%	33,000 $18,000
Q3 2022 Nov 01, 2022	SELL	$0.55 - $0.74 $275 - $370	-500 Reduced 1.52%	32,500 $18,000
Q1 2022 May 05, 2022	BUY	$0.65 - $1.2 $4,875 - $9,000	7,500 Added 29.41%	33,000 $28,000
Q4 2021 Jan 19, 2022	BUY	$0.53 - $1.09 $2,650 - $5,450	5,000 Added 24.39%	25,500 $28,000
Q1 2021 May 10, 2021	BUY	$1.56 - $2.7 $7,800 - $13,500	5,000 Added 32.26%	20,500 $33,000
Q4 2020 Jan 29, 2021	SELL	$0.8 - $2.56 $6,400 - $20,480	-8,000 Reduced 34.04%	15,500 $24,000
Q3 2020 Nov 12, 2020	BUY	$0.79 - $1.52 $4,740 - $9,120	6,000 Added 34.29%	23,500 $2,000
Q2 2020 Aug 13, 2020	BUY	$0.68 - $1.13 $11,900 - $19,774	17,500 New	17,500 $17,000

Ticker AGE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,945,100
Description
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...

Get notified when there are updates to the investment portfolio of Summit X, LLC, based on Form 13F filings with the SEC.

Stay updated on Summit X, LLC with notifications on news.